Alphamab Oncology Management
Management criteria checks 3/4
Alphamab Oncology's CEO is Ting Xu, appointed in Nov 2008, has a tenure of 15.67 years. total yearly compensation is CN¥6.88M, comprised of 95.2% salary and 4.8% bonuses, including company stock and options. directly owns 33.01% of the company’s shares, worth €87.64M. The average tenure of the management team and the board of directors is 5.5 years and 4.7 years respectively.
Key information
Ting Xu
Chief executive officer
CN¥6.9m
Total compensation
| CEO salary percentage | 95.2% |
| CEO tenure | 15.7yrs |
| CEO ownership | 33.0% |
| Management average tenure | 5.5yrs |
| Board average tenure | 4.7yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | CN¥7m | CN¥7m | -CN¥211m |
| Sep 30 2023 | n/a | n/a | -CN¥214m |
| Jun 30 2023 | n/a | n/a | -CN¥218m |
| Mar 31 2023 | n/a | n/a | -CN¥272m |
| Dec 31 2022 | CN¥7m | CN¥6m | -CN¥326m |
| Sep 30 2022 | n/a | n/a | -CN¥309m |
| Jun 30 2022 | n/a | n/a | -CN¥292m |
| Mar 31 2022 | n/a | n/a | -CN¥352m |
| Dec 31 2021 | CN¥7m | CN¥5m | -CN¥412m |
| Sep 30 2021 | n/a | n/a | -CN¥502m |
| Jun 30 2021 | n/a | n/a | -CN¥592m |
| Mar 31 2021 | n/a | n/a | -CN¥510m |
| Dec 31 2020 | CN¥5m | CN¥4m | -CN¥428m |
| Sep 30 2020 | n/a | n/a | -CN¥652m |
| Jun 30 2020 | n/a | n/a | -CN¥877m |
| Mar 31 2020 | n/a | n/a | -CN¥851m |
| Dec 31 2019 | CN¥5m | CN¥3m | -CN¥833m |
Compensation vs Market: Ting's total compensation ($USD946.15K) is about average for companies of similar size in the German market ($USD837.40K).
Compensation vs Earnings: Ting's compensation has increased whilst the company is unprofitable.
CEO
Ting Xu (51 yo)
15.7yrs
Tenure
CN¥6,877,000
Compensation
Dr. Ting Xu, Ph D., serves Chief Executive Officer at Alphamab Oncology since October 1, 2018. He Founded Alphamab Oncology in November 2008.Dr. Xu serves as Executive Director at Alphamab Oncology since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 15.7yrs | CN¥6.88m | 33.01% CN¥ 87.6m | |
| VP of Corporate Operations & Executive Director | 5.8yrs | CN¥2.97m | no data | |
| Director of Investor Relations & Joint Company Secretary | 3.6yrs | no data | no data | |
| Vice President of Government Affairs & Public Relations | 5.5yrs | no data | no data | |
| Senior Vice President of Business Development | 6.2yrs | no data | no data | |
| Chief Commercial Officer | 2.7yrs | no data | no data | |
| Joint Company Secretary | 4yrs | no data | no data |
5.5yrs
Average Tenure
51yo
Average Age
Experienced Management: 3NK's management team is seasoned and experienced (5.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.3yrs | CN¥6.88m | 33.01% CN¥ 87.6m | |
| VP of Corporate Operations & Executive Director | 5.8yrs | CN¥2.97m | no data | |
| Independent Non-Executive Director | 4.7yrs | CN¥396.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 4.7yrs | CN¥396.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 2.9yrs | CN¥378.00k | no data |
4.7yrs
Average Tenure
54yo
Average Age
Experienced Board: 3NK's board of directors are considered experienced (4.7 years average tenure).